Locemia Solutions ULC   Report issue

For profit Phase 1
Founded: Montreal Canada (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2012
NCT02778113
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (3)

glucagon (1 trial)

ly900018 (4 trials)

oxymetazoline (ocuclear) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Common Cold (Phase 1)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Diabetes Mellitus, Type 2 (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 3